Thomas G. Wiggans

Insider Reports History

Entity
Individual
Signature
/s/ Herb Cross, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Thomas G. Wiggans:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Jasper Therapeutics, Inc. Director Voting Common Stock 50K $32.4K $0.65 Nov 28, 2023 Direct
Annexon, Inc. Director Stock Option (Right to Buy) 44K Jun 5, 2024 Direct
Jasper Therapeutics, Inc. Director Stock Option (right to buy) 7.5K Jun 6, 2024 Direct
CymaBay Therapeutics, Inc. Director Employee Stock Option (right to buy) 0 Mar 22, 2024 Direct
Forma Therapeutics Holdings, Inc. Director Common Stock 0 $5.05 Oct 14, 2022 Direct
Forma Therapeutics Holdings, Inc. Director Stock Option (Right to Buy) 0 Oct 14, 2022 Direct
PARDES BIOSCIENCES, INC. Chief Executive Officer, Director Common Stock 0 $1.50 Aug 31, 2023 Direct
PARDES BIOSCIENCES, INC. Chief Executive Officer, Director Stock Option (Right to Buy) 0 Aug 31, 2023 Direct

Insider Reports Filed by Thomas G. Wiggans

Symbol Company Period Transactions Value $ Form Type Date Filed Role
JSPR Jasper Therapeutics, Inc. Jun 6, 2024 1 $0 4 Jun 10, 2024 Director
ANNX Annexon, Inc. Jun 5, 2024 1 $0 4 Jun 7, 2024 Director
CBAY CymaBay Therapeutics, Inc. Mar 22, 2024 4 $0 4 Mar 22, 2024 Director
CBAY CymaBay Therapeutics, Inc. Jan 24, 2024 1 $0 4 Jan 26, 2024 Director
JSPR Jasper Therapeutics, Inc. Nov 28, 2023 1 $6.49K 4 Nov 30, 2023 Director
JSPR Jasper Therapeutics, Inc. Nov 21, 2023 1 $6.38K 4 Nov 22, 2023 Director
JSPR Jasper Therapeutics, Inc. Nov 16, 2023 3 $18.2K 4 Nov 20, 2023 Director
JSPR Jasper Therapeutics, Inc. Nov 1, 2023 1 $0 4 Nov 2, 2023 Director
JSPR Jasper Therapeutics, Inc. Nov 1, 2023 0 $0 3 Nov 2, 2023 Director
PRDS PARDES BIOSCIENCES, INC. Aug 31, 2023 4 $0 4 Aug 31, 2023 Chief Executive Officer, Director
ANNX Annexon, Inc. Jun 8, 2023 1 $0 4 Jun 12, 2023 Director
PRDS PARDES BIOSCIENCES, INC. Feb 1, 2023 1 $0 4 Feb 3, 2023 Chief Executive Officer, Director
CBAY CymaBay Therapeutics, Inc. Jan 25, 2023 1 $0 4 Jan 27, 2023 Director
PRDS PARDES BIOSCIENCES, INC. Dec 5, 2022 1 $13.6K 4 Dec 7, 2022 Chief Executive Officer, Director
PRDS PARDES BIOSCIENCES, INC. Dec 1, 2022 2 $39.4K 4 Dec 5, 2022 Chief Executive Officer, Director
FMTX Forma Therapeutics Holdings, Inc. Oct 14, 2022 4 $0 4 Oct 14, 2022 Director
PRDS PARDES BIOSCIENCES, INC. Sep 14, 2022 1 $0 4 Sep 16, 2022 Chief Executive Officer, Director
ANNX Annexon, Inc. Jun 9, 2022 1 $0 4 Jun 13, 2022 Director
FMTX Forma Therapeutics Holdings, Inc. Jun 8, 2022 2 $0 4 Jun 9, 2022 Director
PRDS PARDES BIOSCIENCES, INC. Mar 2, 2022 1 $0 4 Mar 4, 2022 Chief Executive Officer, Director
PRDS PARDES BIOSCIENCES, INC. Mar 1, 2022 0 $0 3 Mar 4, 2022 Chief Executive Officer, Director
CBAY CymaBay Therapeutics, Inc. Jan 25, 2022 1 $0 4 Jan 27, 2022 Director
FMTX Forma Therapeutics Holdings, Inc. Jun 17, 2021 2 $0 4 Jun 21, 2021 Director
ANNX Annexon, Inc. Jun 2, 2021 1 $0 4 Jun 4, 2021 Director